Physician

Richard Pearlman, MD

According to 2025 Medicare claims, Richard Pearlman, MD (NPI: 1639526874) practices radiation oncology in the Florence-Muscle Shoals, AL market, with the plurality of this provider's patient population coming from Lauderdale, AL. This provider's primary affiliated billing organization is CENTER FOR CANCER CARE LLC (NPI: 1982629648; TIN: 63-1185834) and primary practice location at 35630-3263.

Pearlman's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 399 traditional Medicare patients, billed 6,645 HCPCS/CPT codes, and received $1,245,140 in Medicare payments. The top billing code was 77263 (Complex radiation therapy planning). Part D data shows 362 prescription claims across 121 beneficiaries totaling $4,829 in drug costs, led by Memantine Hcl Er (Memantine Hcl). 2023 DME data shows 12 claims. Open Payments data shows 12 records totaling $278. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have risen steadily, from $2,211 to $4,829. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$691K$1.4M2021 Medicare payment: $455,306 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $977,932 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,381,016 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,245,140 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
20211222,627$455,306
20222735,789$977,932
20233177,874$1,381,016
20243996,645$1,245,140

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.9K$5.9K2016 Drug cost: $2,211 (USD; Tot_Drug_Cst)2017 Drug cost: $188 (USD; Tot_Drug_Cst)2018 Drug cost: $360 (USD; Tot_Drug_Cst)2019 Drug cost: $200 (USD; Tot_Drug_Cst)2020 Drug cost: $568 (USD; Tot_Drug_Cst)2021 Drug cost: $2,255 (USD; Tot_Drug_Cst)2022 Drug cost: $5,858 (USD; Tot_Drug_Cst)2023 Drug cost: $5,788 (USD; Tot_Drug_Cst)2024 Drug cost: $4,829 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
20161630$2,211
2017N/R21$188
2018N/R24$360
2019N/R16$200
20201324$568
20213064$2,255
202272194$5,858
202397269$5,788
2024121362$4,829

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$294$5872023 Medicare payment: $587 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021N/RN/RN/R
2022N/RN/RN/R
2023N/R12$587
2024N/RN/RN/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
77263Complex radiation therapy planning131134$130
77334Design and construction of complex radiation treatment device124316$96
77336Continuing radiation therapy consultation per week126425$64
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more162232$62
77300Calculation of radiation therapy dose117393$50

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Memantine Hcl ErMemantine Hcl21605$1,135
Tamsulosin HclTamsulosin Hcl1024,445$822
SucralfateSucralfate27480$458
Lidocaine Hcl ViscousLidocaine Hcl52452$448
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen29233$437

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.12$278AstraZeneca Pharmaceuticals LP
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Richard Pearlman, MD?

Tedicare shows public-source Medicare data for Richard Pearlman, MD (NPI 1639526874), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Richard Pearlman, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Richard Pearlman, MD?

Richard Pearlman, MD is linked to CENTER FOR CANCER CARE LLC (billing NPI 1982629648) in the available physician profile data.

Does Richard Pearlman, MD have Open Payments data?

Richard Pearlman, MD has 12 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.